Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 47, 3650-3655, July 15, 1987]
© 1987 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirkin, B. L.
Right arrow Articles by Hogenkamp, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirkin, B. L.
Right arrow Articles by Hogenkamp, H. P.

Cytotoxic Action of Adenosine Nucleoside and Dialdehyde Analogues on Murine Neuroblastoma in Tissue Culture: Structure-Activity Relationships1

Bernard L. Mirkin2, Robert F. O'Dea and Harry P. Hogenkamp

Division of Clinical Pharmacology, Departments of Pediatrics, Pharmacology, and Biochemistry, University of Minnesota, Health Sciences Center, Minneapolis, Minnesota 55455

A series of purine nucleoside and dialdehyde analogues was studied to determine their potency as inhibitors of C-1300 murine neuroblastoma cell growth in tissue culture. Tumor cells were incubated with each analogue for 72 h, and the number of viable cells was determined at 24, 48, and 72 h. Dose-response curves were generated (concentration range, 10-8 to 10-3 M), and the drug concentration producing 50% inhibition of cell growth was calculated for each analogue. The 50% inhibitory concentrations, in ascending order of potency, were as follows: adenosine (inactive); S-adenosylhomocysteine (inactive); methylfuryladenine (5.6 x 10-1 M); adenosine 5'-carboxylic acid (2.0 x 10-1 M); 5'-chloro, 5'-deoxy-ara-adenosine (3.0 x 10-2 M); sinefungin (1.7 x 10-3 M); 5'-deoxyadenosine (2.2 x 10-4 M); 5'-chloro, 5'-deoxyadenosine (2.1 x 10-4 M); 3',5'-dichloro, 2',3',5'-trideoxyadenosine (1.3 x 10-4 M); 3-deazaadenosine (5.6 x 10-5 M); and adenosine dialdehyde (1.5 x 10-6 M).

Oxidation of the pentose to a dialdehyde increased, whereas reduction of the dialdehyde or substitution of adenine with either hypoxanthine, guanine, uracil, or cytosine decreased the inhibitory potency. The analogues 4',5'-anhydroadenosine dialdehyde and 5'-deoxyadenosine dialdehyde, which cannot be phosphorylated at the 5' position, had 50% inhibitory concentrations of 9.1 x 10-6 and 7.6 x 10-6 M, respectively.

These data suggest that the inhibitory action and potency of nucleoside dialdehydes on neuroblastoma growth are independent of their capacity to undergo a kinase-mediated phosphorylation at the 5' position.

1 This investigation was supported by Grants NS17194, National Institute of Neurological and Communicable Diseases and Stroke, and GM 33776, National Institute of General Medical Science.

2 To whom requests for reprints should be addressed, at Division of Clinical Pharmacology, University of Minnesota, Health Sciences Center, Mayo Building, Box 87, 420 Delaware Street S.E., Minneapolis, MN 55455.

Received 10/24/86. Revised 3/30/87. Accepted 4/16/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1987 by the American Association for Cancer Research.